Skip to main content
NVDA+0.14%AAPL-0.11%GOOGL+1.56%MSFT-0.11%AMZN-0.06%TSM+2.96%SPCX+7.35%META-0.06%AVGO+3.35%TSLA+0.21%SKHY+0.84%MU-0.46%BRK-B+0.43%LLY-0.61%AMD+2.95%JPM-0.24%WMT0.00%ASMLa+3.51%XOM+0.12%V+0.23%JNJ-1.02%INTC-0.56%0700.HK-0.02%MA+0.41%ABBV+1.11%1398.HK-0.23%CSCO+3.16%LRCX+2.17%AMAT+2.03%AP2d+2.88%CVX-0.20%ORCL+3.06%COST+0.62%CAT+2.31%BAC+0.04%DELL+3.82%KO-0.52%PG+0.67%UNH+1.83%0005.HK-0.11%ARM+5.18%HSBA.L+0.36%3988.HK-0.21%GE-0.91%1816.HK-28.01%MS+1.22%0857.HK-0.21%0939.HK-0.58%PM-0.38%1288.HK-0.58%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPNZD0.00%GBPSGD0.00%GBPZAR0.00%EURSEK0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%GBPCAD0.00%USDPLN0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%CADCHF0.00%NZDJPY0.00%EURDKK0.00%USDZAR0.00%USDHKD0.00%CADJPY0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.30%ETHUSD+7.80%USDTUSD+0.01%XRPUSD+1.02%SOLUSD-0.22%TRXUSDT+0.28%ZECUSDT+0.35%DOGEUSD+0.81%XMRUSDT+0.86%LINKUSD+3.68%XLMUSD-0.28%BCHUSDT+1.94%UNIUSD+1.07%LTCUSD-4.30%SUIUSD+2.63%HBARUSDT-1.46%TONUSD+14.41%TAOUSDT+4.35%AAVEUSD+1.08%DOTUSDT+1.94%ICPUSDT+0.74%WLDUSDT+16.22%ONDOUSDT+0.55%ARBUSDT+2.79%JUPUSDT+3.89%ATOMUSDT+3.27%INJUSDT+1.74%STXUSDT+2.37%FETUSDT+1.29%SEIUSDT+3.20%PYTHUSDT-1.33%TIAUSDT+4.79%IMXUSDT+4.63%GRTUSDT-1.06%OPUSDT+4.95%WIFUSDT-0.28%IOTAUSDT+1.35%AXSUSDT+6.16%POLUSDT+1.82%FARTCOINUSDT-1.21%EOSUSDT-1.22%DYDXUSDT-0.58%GALAUSDT-4.59%ORDIUSDT-0.41%NOTUSDT-1.09%RONINUSDT+4.17%NVDA+0.14%AAPL-0.11%GOOGL+1.56%MSFT-0.11%AMZN-0.06%TSM+2.96%SPCX+7.35%META-0.06%AVGO+3.35%TSLA+0.21%SKHY+0.84%MU-0.46%BRK-B+0.43%LLY-0.61%AMD+2.95%JPM-0.24%WMT0.00%ASMLa+3.51%XOM+0.12%V+0.23%JNJ-1.02%INTC-0.56%0700.HK-0.02%MA+0.41%ABBV+1.11%1398.HK-0.23%CSCO+3.16%LRCX+2.17%AMAT+2.03%AP2d+2.88%CVX-0.20%ORCL+3.06%COST+0.62%CAT+2.31%BAC+0.04%DELL+3.82%KO-0.52%PG+0.67%UNH+1.83%0005.HK-0.11%ARM+5.18%HSBA.L+0.36%3988.HK-0.21%GE-0.91%1816.HK-28.01%MS+1.22%0857.HK-0.21%0939.HK-0.58%PM-0.38%1288.HK-0.58%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPNZD0.00%GBPSGD0.00%GBPZAR0.00%EURSEK0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%GBPCAD0.00%USDPLN0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%CADCHF0.00%NZDJPY0.00%EURDKK0.00%USDZAR0.00%USDHKD0.00%CADJPY0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+0.30%ETHUSD+7.80%USDTUSD+0.01%XRPUSD+1.02%SOLUSD-0.22%TRXUSDT+0.28%ZECUSDT+0.35%DOGEUSD+0.81%XMRUSDT+0.86%LINKUSD+3.68%XLMUSD-0.28%BCHUSDT+1.94%UNIUSD+1.07%LTCUSD-4.30%SUIUSD+2.63%HBARUSDT-1.46%TONUSD+14.41%TAOUSDT+4.35%AAVEUSD+1.08%DOTUSDT+1.94%ICPUSDT+0.74%WLDUSDT+16.22%ONDOUSDT+0.55%ARBUSDT+2.79%JUPUSDT+3.89%ATOMUSDT+3.27%INJUSDT+1.74%STXUSDT+2.37%FETUSDT+1.29%SEIUSDT+3.20%PYTHUSDT-1.33%TIAUSDT+4.79%IMXUSDT+4.63%GRTUSDT-1.06%OPUSDT+4.95%WIFUSDT-0.28%IOTAUSDT+1.35%AXSUSDT+6.16%POLUSDT+1.82%FARTCOINUSDT-1.21%EOSUSDT-1.22%DYDXUSDT-0.58%GALAUSDT-4.59%ORDIUSDT-0.41%NOTUSDT-1.09%RONINUSDT+4.17%
VI

Viatris Inc. (VTRS)

NASDAQ • Healthcare

$17.6
+$0.14 (+0.8%)
Market closed

Last close at October 2, 2026 at 20:00 UTC

Open$17.53
Day Range$17.34 - $17.65
Avg. Volume (3M)9.2M
Market Cap$20.4B
52 Week Range
$9.69$18.43
Next EarningsIn 32 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$3.7B100%
Gross Profitminus cost of goods$1.4B39%
Operating Incomeminus R&D and overhead$6.3M0%

In plain terms: out of every $100 in revenue, Viatris Inc. currently loses $3.

Fundamentals & Financials

Revenue (TTM)
$14.7B
Net Income (TTM)
-$410.6M
EPS (TTM)
-$0.36
ROA (TTM)
-1.17%
Current Ratio
1.58
Dividend Yield
0.76%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+7.1%Q1 2026$0.57
+17.5%Q2 2026$0.59
+14.8%Q3 2026$0.69
Next

Nov 5

in 32 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +14.8%

Viatris Inc. beat on both the top and bottom line in the second fiscal quarter of 2026, based on preliminary results reported Aug. 6. Revenue rose 4.9% to about $3.8 billion, topping the about $3.7 billion consensus by 2.2%, while gross margin held near 39% and gross profit reached about $1.5 billion. Adjusted EPS of $0.69 beat the $0.60 estimate by 14.8% and improved 11.3% from $0.62 a year ago, while net income came in at negative about $119 million, down 2482.6% from negative $4.6 million a year ago. Brands, the largest segment, generated about $2.3 billion, up 10.2% year over year. Operating cash flow totaled about $770 million, and Viatris repurchased about $150 million of stock and paid about $279 million in dividends. Consensus for the next period calls for EPS of $0.65 on revenue of $3.82 billion.

View full earnings history

About Viatris Inc.

Viatris Inc. operates in healthcare as a maker of branded, generic, and specialty medicines, trading on NASDAQ under VTRS. Its portfolio spans treatments from Lyrica and Lipitor to biosimilars and raw pharmaceutical ingredients, and it generated $14.3 billion of revenue in FY2025.

Name
Viatris Inc.
CEO
Scott Andrew Smith
Industry
Healthcare
Year Founded
1961
Employees
30,000

Today's Snapshot

AI-generated

The day ended with VTRS 0.8% higher at 17.60, while its sector was flat. VTRS closed within 4.5% of its 52-week high of 18.43.

Trading Volume

Below 10d avg (9.7M)

7.2M

vs S&P 500 Today

Inline with Market

+0.02%

Updated: October 2, 2026 at 20:15 UTC

Technical Indicators

6 Buy2 Neutral0 Sell
VTRS presents a strong buy profile based on a clear alignment of momentum, rising moving averages and improving trend strength. The stock trades above its short-, medium- and long-term averages and both momentum and the MACD are positive, while ADX indicates a strengthening trend and OBV confirms bullish participation. Volatility is contained, and the near-term pivot is in-line with the market. Technical takeaway: broad-based trend and volume support a robust bullish setup with measured volatility.
All signals
  • EMA (5 indicators)$15.00 - $17.55
    Buy
  • RSI (14)57.35
    Neutral
  • Stochastic %K (14, 3, 3)59.52
    Neutral
  • MACD Level (12, 26)0.29
    Buy
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.